IgA Nephropathy: Understanding Racial and Gender Differences in Epidemiology

IgA nephropathy (IgAN) is the most common primary glomerulonephritis worldwide. Epidemiology reveals striking disparities.

Racial/Ethnic Distribution

  • Asian populations: Highest prevalence (2–10% of biopsies in East/Southeast Asia); genetic susceptibility loci (e.g., HLA-DRB1*, DEFA, TNFSF13).
  • White populations: Intermediate (1–2% of biopsies in Europe/NA).
  • Black populations: Lower biopsy prevalence but more aggressive course, faster progression to ESKD; APOL1 risk variants may modify.
  • Hispanic/Latino: Variable; limited data.

Gender Differences

  • Male predominance: 2:1 to 3:1 in most series.
  • Men present younger, with more proteinuria, faster progression.
  • Women: later onset, more likely asymptomatic hematuria; pregnancy can unmask/worsen.
  • Hormonal modulation of immune response and mucosal immunity hypothesized.

Contributing Factors

  • Genetic architecture (GWAS loci differ by ancestry).
  • Environmental: infections (mucosal), diet, microbiome.
  • Socioeconomic: access to care, biopsy rates, follow-up adherence.
  • Ascertainment bias: screening practices (Asia: school/workplace urinalysis).

Clinical Implications

  • Risk stratification tools (e.g., IgAN Prediction Tool) incorporate race/sex.
  • Clinical trial diversity needed for generalizable therapies (sparsentan, budesonide, narsoplimab, SGLT2i).
  • Culturally sensitive counseling on prognosis, family screening.

Understanding disparities improves equity in diagnosis, monitoring, and access to emerging therapies.

Kidney Disease - Related Articles